Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development
12 February 2024
- Meet Farah Alasali, Senior Officer in our Social Responsibility team based in Jordan. Hear what she has to say about life at Hikma. #OwnYourCareer Story, Life at Hikma 02 July 2025 Meet Farah Alasali, Senior Officer in our Social Responsibility team based in Jordan. Hear what she has to say about life at Hikma. #OwnYourCareer
- Hikma receives FDA approval for TYZAVANTM (Vancomycin Injection, USP) in the US Press Release, Product 02 July 2025 Hikma receives FDA approval for TYZAVANTM (Vancomycin Injection, USP) in the US
- Hikma publishes its 2024 Sustainability Report reinforcing commitment to global access to medicines Press Release, Corporate 30 June 2025 Hikma publishes its 2024 Sustainability Report reinforcing commitment to global access to medicines
- Hikma R&D – Innovating analytical research: meet Samuel Cook Story, Life at Hikma 30 June 2025 Hikma R&D – Innovating analytical research: meet Samuel Cook
Related content